Echocardiographic features of atrial myocarditis with giant cells: A case report

Journal of the American Society of Echocardiography

Volumn 17, Issue 10, 2004, Pages 1073-1076

  Law, Kwan K ^a   Binder, Josepha ^a   Cooper, Leslie T ^a   Specks, Ulrich ^a   Tazelaar, Henry D ^a   Seward, James B ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

ADULT; ANTIBODY DETECTION; ARTICLE; CASE REPORT; ENDOTHELIUM LESION; FEMALE; GIANT CELL; HEART ATRIUM; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; MYOCARDITIS; PULMONARY VEIN; RESTRICTIVE CARDIOMYOPATHY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; GIANT CELLS; HEART ATRIA; HUMANS; MIDDLE AGED; MYOCARDITIS; MYOCARDIUM; PULMONARY VEINS; WEGENER GRANULOMATOSIS;

EID: 4644233928     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.echo.2004.04.029     Document Type: Article

References (12)

1. Oh J.K., Seward J.B., Tajik A.J. The echo manual. 2nd ed :1999;163-165 Lippincott Williams and Wilkins, Philadelphia
2. Goodfield N.E., Bhandari S., Plant W.D., Morley-Davies A., Sutherland G.R. Cardiac involvement in Wegener's granulomatosis. Br Heart J. 73:1995;110-115
3. Forstot J.Z., Overlie P.A., Neufeld G.K., Harmon C.E., Forstot S.L. Cardiac complications of Wegener granulomatosis a case report of complete heart block and review of the literature. Semin Arthritis Rheum. 10:1980;148-154
4. Oliveira G.H.M., Seward J.B., Specks U. Cardiac involvement in Wegener's granulomatosis echocardiographic features and clinical outcomes [abstract]. Cleve Clin J Med. 69:2002;SII-103
5. Cooper L.T. Jr, Berry G.J., Shabetai R. for the Multicenter Giant Cell Myocarditis Study Group Investigators. Idiopathic giant-cell myocarditis natural history and treatment. N Engl J Med. 336:1997;1860-1866
6. Tsang T.S., Barnes M.E., Gersh B.J., Bailey K.R., Seward J.B. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol. 90:2002;1284-1289
7. Masor J.J., Gal A.A., LiVolsi V.A. Case report Hashimoto's thyroiditis associated with Wegener's granulomatosis. Am J Med Sci. 308:1994;112-114
8. Kedziora J.A., Wolff M., Chang J. Limited form of Wegener's granulomatosis in ulcerative colitis. Am J Roentgenol Radium Ther Nucl Med. 125:1975;127-133
9. Wu L.A., Lapeyre A.C. III, Cooper L.T. Current role of endomyocardial biopsy in the management of dilated cardiomyopathy and myocarditis. Mayo Clin Proc. 76:2001;1030-1038
10. Hojnik M., George J., Ziporen L., Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation. 93:1996;1579-1587
11. Leavitt R.Y., Fauci A.S., Bloch D.A., Michel B.A., Hunder G.G., Arend W.P., et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 33:1990;1101-1107
12. Nölle B., Specks U., Lüdemann J., Rohrbach M.S., DeRemee R.A., Gross W.L. Anticytoplasmic autoantibodies their immunodiagnostic value in Wegener granulomatosis. Ann Intern Med. 111:1989;28-40